CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature
Journal of the National Comprehensive Cancer Network · 05.04.2024 · 22 (2.5)
DOI: 10.6004/jnccn.2023.7307 ↗Kurz gefasst
Fallbericht in der Zeitschrift Journal of the National Comprehensive Cancer Network, erschienen am 05.04.2024. Verfasst von Charlotte S Walmsley und 5 weiteren Autor:innen. Beteiligte Einrichtung: 1Beth Israel Deaconess Medical Center, Boston, MA. Die Arbeit wurde bisher 2-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Autor:innen und Institutionen
- 1Beth Israel Deaconess Medical Center, Boston, MA.
Zitieren
APA
Walmsley, C. S., Andersen, M., Lam, B., Rangachari, D., Berwick, S., & Patell, R. (2024). CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature. Journal of the National Comprehensive Cancer Network, 22(2.5). https://doi.org/10.6004/jnccn.2023.7307
Vancouver
Walmsley CS, Andersen M, Lam B, Rangachari D, Berwick S, Patell R. CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature. Journal of the National Comprehensive Cancer Network. 2024;22(2.5). doi:10.6004/jnccn.2023.7307
BibTeX
@article{Walmsley2024,
author = {Walmsley, Charlotte S and Andersen, Michael and Lam, Barbara and Rangachari, Deepa and Berwick, Shana and Patell, Rushad},
title = {CRE24-035: Pembrolizumab-Induced Hemophagocytic Lymphohistiocytosis in a Patient With Breast Cancer: A Case Report and Systematic Review of the Literature},
journal = {Journal of the National Comprehensive Cancer Network},
year = {2024},
volume = {22},
number = {2.5},
doi = {10.6004/jnccn.2023.7307}
}
EUVIMED